Kaiser Permanente inks vendor agreements
Two vendors have won significant sales contracts with Kaiser Permanente. Emageon will provide diagnostic image archiving, while SonoSite will supply handheld ultrasound scanners.Kaiser Permanente will use Emageon's Enterprise Archive Manager for DICOM
Two vendors have won significant sales contracts with Kaiser Permanente. Emageon will provide diagnostic image archiving, while SonoSite will supply handheld ultrasound scanners.
Kaiser Permanente will use Emageon's Enterprise Archive Manager for DICOM software suite to provide archiving capabilities for acute-care hospitals and clinics. The five-year contract covers all U.S. Kaiser Permanente facilities. The archive manager is described by the HMO as a highly scalable, standards-based product that will serve as a key component in its overall PACS strategy and infrastructure. When fully deployed, Emageon's software technology is expected to help manage more than six million diagnostic studies per year for Kaiser Permanente.
SonoSite's agreement will bring it at least $2 million in product sales over a two-year term. Further sales could accrue as part of an optional two-year renewal. The highly portable ultrasound systems will be used in all imaging applications and clinical settings. SonoSite executives described the agreement as a milestone for the company, capping a more than three-year effort during which the company sought input from physicians and management leaders at Kaiser Permanente.
FDA Grants Fast Track Designation to Emerging Agent for Brain PET Imaging
June 11th 2025Currently being evaluated in a phase 2b clinical trial, the 18F-RAD101 PET imaging agent garnered the FDA’s fast track designation for distinguishing between recurrent disease and treatment impact for brain metastases derived from solid tumors.
New PSMA PET Prep Product Now Available in the U.S.
June 11th 2025Offering an extended shelf life, the FDA-approved Gozellix, a preparation kit for gallium-68 (68Ga) gozetotide injection, is indicated for use in PSMA PET imaging of prostate cancer patients with suspected recurrence or metastasis.
